DERClass II
Alpha-1-Lipoprotein, Antigen, Antiserum, Control
21 CFR 866.5580 / Immunology
DER is the FDA product code for Alpha-1-Lipoprotein, Antigen, Antiserum, Control, a class II device type, regulated under 21 CFR 866.5580. As of , FDA records hold 17 510(k) clearances under this code, the most recent dated , and 2 recalls.
Classification record
- Product code
- DER
- Device name
- Alpha-1-Lipoprotein, Antigen, Antiserum, Control
- Regulation
- 21 CFR 866.5580
- Device class
- Class II
- Review panel
- Immunology
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- Yes
- Ingested clearances
- 17
- Ingested recalls
- 2
Clearances, product code DER
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 1981 | 1 |
| 1984 | 1 |
| 1985 | 2 |
| 1986 | 1 |
| 1987 | 1 |
| 1990 | 1 |
| 1991 | 1 |
| 1997 | 3 |
| 1999 | 4 |
| 2000 | 1 |
| 2001 | 1 |
Applicants with the most clearances
Product code DER| Applicant | Clearances |
|---|---|
| Crestat Diagnostics, Inc. | 3 |
| Photec Diagnostics, Inc. | 3 |
| Kamiya Biomedical Company, LLC | 2 |
| Roche Diagnostics GmbH | 2 |
| Abbott Medical | 1 |
| Bayer Corp. | 1 |
| Eucardio Laboratory, Inc. | 1 |
| Hyland Therapeutic Div., Travenol Laboratories | 1 |
| Roche Diagnostic Systems, Inc. | 1 |
| Solomon Park Research Laboratories, Inc. | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
